Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Extension for Community Health Outcomes (ECHO) Diabetes Program
NCT06552923 · View on ClinicalTrials.gov ↗
Study Summary
The Project ECHO model is currently used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach using a "hub" and "spoke" learning model. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs. This study evaluated implementation of an ECHO Diabetes program on patient-level, provider-level, and center-level outcomes in underserved populations receiving diabetes care from primary care providers. Participants: Twenty Federally Qualified Health Centers (FQHCs) and FQHC "look alikes" across CA and FL were recruited to participate as spokes in the ECHO Diabetes trial. A stepped-wedge trial design was used with randomized, phased-in intervention entry for participating health centers (or "spokes"). Interventions: Spokes were provided access to 6-months of tele-education sessions with continuing medical education credits, access to real-time support for complex medical decision making with hub subspecialty teams, and access to a diabetes support coach. Main outcomes and Measures: Participating FQHCs ("spokes") provided aggregate data including Healthcare Effectiveness Data and Information Set (HEDIS) reporting on the % of patients with HbA1c \>9%.
Conditions Studied
Interventions
- OTHER ECHO Tele-Education
Study Locations (17)
California
- CommuniCare Davis Family Health Center — Davis
- St Agnes Medical Center — Fresno
- La Clinica — Multiple Locations
- Santa Rosa Community Health Centers — Multiple Locations
- Shasta Community Health Centers — Multiple Locations
- Health Service Alliance — Rancho Cucamonga
- Hill Country Community Clinic — Redding
- CommuniCare Salud Family Health — West Sacramento
- CommuniCare Hansen Family Center — Woodland
Florida
- Premier Community Health — Dade City
- Community Health of South Florida (CHI) — Homestead
- Banyan Health Systems — Miami
- Borinquen Medical Center — Miami
- Orange Blossom Family Health — Orlando
- Evara Health System — Pinellas Park
- Tampa Family Health Center — Tampa
- Treasure Coast Community Health — Vero Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,796 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06552923
The ClinicalTrials.gov registry entry for NCT06552923 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 32,796 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,066 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention — of which ECHO Tele-Education is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06552923 reports 17 study locations spanning 2 distinct geographic areas — top geographies include California, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06552923 about?
NCT06552923 is a clinical study titled "Extension for Community Health Outcomes (ECHO) Diabetes Program". The Project ECHO model is currently used in 180 countries to address chronic disease care through a provider empowerment, tele-education approach using a "hub" and "spoke" learning model. Few studies have rigorously evaluated the impact of the program on patient outcomes using randomized designs. Th...
What is the current status of trial NCT06552923?
This trial is currently completed. It is a NA study. The enrollment target is 32,796 participants. The study started on 2021-06-01. Estimated completion is 2023-12-31.
What conditions does trial NCT06552923 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06552923?
The interventions under investigation include: ECHO Tele-Education (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06552923?
This trial is sponsored by University of Florida, which has 1,066 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06552923 being conducted?
This trial has 17 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.